QLOSI

Growth

pilocarpine hydrochloride

Orasis Pharmaceuticals

NDAOPHTHALMICSOLUTION/DROPS

Approved

Oct 2023

Lifecycle

Growth

Competitive Pressure

0/100

Loss of Exclusivity

LOE Date

Aug 18, 2037

139 months away

Patent Expiry

Aug 18, 2037

Exclusivity Expiry

Oct 17, 2026

Patent Records (4)

Patent #	Expiry	Type	Use Code
10639297	Aug 18, 2037	Product	U-3741
11129812	Aug 18, 2037		U-3741
11974986	Aug 18, 2037		U-3741
9867810	Aug 18, 2037	Product	U-3741

Company

Orasis Pharmaceuticals

Israel - Herzliya

External Resources

Full prescribing information

FDA approval history

Drug nomenclature & identifiers